Maedeh Raznahan

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

Shahin Akhondzadeh, Sara Jafari, Firoozeh Raisi et al. · Depression and Anxiety · 2009 · 394 citations

Medicine, Pharmacology, Pharmacotherapy +17

Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism

Shahin Akhondzadeh, Jalil Fallah, Mohammad-Reza Mohammadi et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2009 · 112 citations

Medicine, Pharmacology, Pharmacotherapy +14

Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: A double-blind randomized placebo-controlled study

Shahin Akhondzadeh, Mojgan Malek-Hosseini, Maedeh Raznahan et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2008 · 76 citations

Medicine, Pharmacology, Psychiatry +13

The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial

Seyed-Hesameddin Abbasi, Haleh Behpournia, Aboulfazl Ghoreshi et al. · Schizophrenia Research · 2009 · 74 citations

Pharmacy, Pharmacotherapy, Psychiatry +14

Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression

Roya Abolfazli, Mahdi Hosseini, Ahmad Ghanizadeh et al. · Depression and Anxiety · 2011 · 60 citations

Medicine, Pharmacotherapy, Psychiatry +16